Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease

被引:173
作者
Bilodeau, Steve
Vallette-Kasic, Sophie
Gauthier, Yves
Figarella-Branger, Dominique
Brue, Thierry
Berthelet, France
Lacroix, Andre
Batista, Dalia
Stratakis, Constantine
Hanson, Jeanette
Meij, Bjorn
Drouin, Jacques
机构
[1] Clin Res Inst Montreal, Genet Mol Lab, Montreal, PQ H2W 1R7, Canada
[2] Univ Mediterranee, Lab Interact Cellulaires Neuroendocriniennes, Inst Jean Roche, CNRS,UMR 6544, F-13385 Marseille, France
[3] CHUM, Hotel Dieu, Dept Med, Res Ctr, Montreal, PQ H2W 1T8, Canada
[4] NICHHD, Dev Endocrinol Branch, SEGEN, Bethesda, MD 20892 USA
[5] Univ Utrecht, Fac Vet Med, Dept Clin Sci & Compan Anim, NL-3508 TD Utrecht, Netherlands
关键词
repression; nuclear receptor; Swi/Snf; pituitary tumors; POMC; Cushing;
D O I
10.1101/gad.1444606
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Negative feedback regulation of the proopiomelanocortin ( POMC) gene by the glucocorticoid (Gc) receptor (GR) is a critical feature of the hypothalamo-pituitary-adrenal axis, and it is in part exerted by trans-repression between GR and the orphan nuclear receptors related to NGFI-B. We now show that Brg1, the ATPase subunit of the Swi/Snf complex, is essential for this trans-repression and that Brg1 is required in vivo to stabilize interactions between GR and NGFI-B as well as between GR and HDAC2. Whereas Brg1 is constitutively present at the POMC promoter, recruitment of GR and HDAC2 is ligand-dependent and results in histone H4 deacetylation of the POMC locus. In addition, GR-dependent repression inhibits promoter clearance by RNA polymerase II. Thus, corecruitment of repressor and activator at the promoter and chromatin modification jointly contribute to trans-repression initiated by direct interactions between GR and NGFI-B. Loss of Brg1 or HDAC2 should therefore produce Gc resistance, and we show that similar to 50% of Gc-resistant human and dog corticotroph adenomas, which are the hallmark of Cushing disease, are deficient in nuclear expression of either protein. In addition to providing a molecular basis for Gc resistance, these deficiencies may also contribute to the tumorigenic process.
引用
收藏
页码:2871 / 2886
页数:16
相关论文
共 51 条
[1]   Diagnosis and complications of Cushing's syndrome: A consensus statement [J].
Arnaldi, G ;
Angeli, A ;
Atkinson, AB ;
Bertagna, X ;
Cavagnini, F ;
Chrousos, GP ;
Fava, GA ;
Findling, JW ;
Gaillard, RC ;
Grossman, AB ;
Kola, B ;
Lacroix, A ;
Mancini, T ;
Mantero, F ;
Newell-Price, J ;
Nieman, LK ;
Sonino, N ;
Vance, ML ;
Giustina, A ;
Boscaro, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12) :5593-5602
[2]   Rb enhances p160/SRC coactivator-dependent activity of nuclear receptors and hormone responsiveness [J].
Batsché, E ;
Desroches, J ;
Bilodeau, S ;
Gauthier, Y ;
Drouin, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (20) :19746-19756
[3]   Retinoblastoma and the related pocket protein p107 act as coactivators of NeuroD1 to enhance gene transcription [J].
Batsché, E ;
Moschopoulos, P ;
Desroches, J ;
Bilodeau, S ;
Drouin, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (16) :16088-16095
[4]   Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain [J].
Cho, EJ ;
Kobor, MS ;
Kim, M ;
Greenblatt, J ;
Buratowski, S .
GENES & DEVELOPMENT, 2001, 15 (24) :3319-3329
[5]   Localized recruitment of a chromatin-remodeling activity by an activator in vivo drives transcriptional elongation [J].
Corey, LL ;
Weirich, CS ;
Benjamin, IJ ;
Kingston, RE .
GENES & DEVELOPMENT, 2003, 17 (11) :1392-1401
[6]  
Cushing H, 1932, B JOHNS HOPKINS HOSP, V50, P137
[7]   The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1:: Molecular mechanisms for gene repression [J].
De Bosscher, K ;
Vanden Berghe, W ;
Haegeman, G .
ENDOCRINE REVIEWS, 2003, 24 (04) :488-522
[8]   Clinical development of histone deacetylase inhibitors as anticancer agents [J].
Drummond, DC ;
Noble, CO ;
Kirpotin, DB ;
Guo, ZX ;
Scott, GK ;
Benz, CC .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 :495-528
[9]   Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex [J].
Fryer, CJ ;
Archer, TK .
NATURE, 1998, 393 (6680) :88-91
[10]   TISSUE-SPECIFIC REGULATION OF PITUITARY PROOPIOMELANOCORTIN GENE-TRANSCRIPTION BY CORTICOTROPIN-RELEASING HORMONE, 3',5'-CYCLIC ADENOSINE-MONOPHOSPHATE, AND GLUCOCORTICOIDS [J].
GAGNER, JP ;
DROUIN, J .
MOLECULAR ENDOCRINOLOGY, 1987, 1 (10) :677-682